AzTrials
AzTrials

Autism Spectrum DisorderNCT04418492

An Intervention Targeting Daily Adaptive Skills Through Executive Function Training for Adults With ASD

A study testing Skills for Adaptive Functioning through Executive training (SAFE; tentative title) in people with Autism Spectrum Disorder and High-functioning Autism, run by Seoul National University Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current study is a single group pilot study of a novel intervention program which targets improvements in executive functions and adaptive skills in transition age young adults with high-functioning autism spectrum disorder. Read more about this study

Who is it for?
Ages 18 to 35 years
What is being tested?
Skills for Adaptive Functioning through Executive training (SAFE; tentative title)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7 participants
Where
1 siteSouth Korea
Study dates
11 Dec 2019to 11 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • A clinical diagnosis of ASD as measured by the Autism Diagnostic Observation Schedule and the Autism Diagnostic Interview-Revised
  • Full-scale IQ of 70 or above as measured by the Weschler Adult Intelligence Scale

Who cannot join

  • Full-scale IQ less than 70
  • Uncooperative and lacking motivation to participate in the programme
  • Reporting clinically significant behavioural problems, emotion regulation problems, psychotic symptoms, risk of self-harm or harm to others which can affect the participation to the programme, which is screened by the screening assessments and interviews.

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do

Other trials in South Korea

About this study

Official title: An Intervention Program Targeting Daily Adaptive Skills Through Executive Function Training for Adults With Autism Spectrum Disorder: A Pilot Study

The current study is a single group pilot study of a novel intervention program which targets improvements in executive functions and adaptive skills in transition age young adults with high-functioning autism spectrum disorder. The main aim of the study is to test the effectiveness of the intervention using a pretest-posttest comparison. It is hypothesised that there will be an increase in executive functions and adaptive skills after the intervention.

Read the detailed description

The participants engaged in a 10-week group-based intervention program which aims to improve daily adaptive skills based on executive functions and help the transition into adulthood in young adults with ASD. Before and after the intervention, the participants and their parents completed questionnaires that measure executive functions and adaptive skills, and the participants additionally completed an assessment of social adaptive skills. The differences between pre- and post-intervention scores of the outcome measures were analyzed using Wilcoxon signed-rank tests to evaluate the effect of the program.

Being tested
Skills for Adaptive Functioning through Executive training (SAFE; tentative title)
Keywords
Autism Spectrum Disorder, High-functioning Autism, Autism, Executive Function, Intervention
Medical subject headings
Autism Spectrum Disorder, Autistic Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Skills for Adaptive Functioning through Executive training (SAFE; tentative title)Behavioural

    An intervention program to improve adaptive skills and executive functions in young adults with high-functioning autism spectrum disorder was administered weekly for 10 weeks to the participants. The participants also completed pre-, mid- and post-intervention assessments.

Study groups in NCT04418492
Study groupRoleWhat they receive
SAFE interventionExperimentalThe single group received the SAFE intervention for 10 weeks.
Receives: Behavioral: Skills for Adaptive Functioning through Executive training (SAFE; tentative title)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The change in the Korean version of Barkley Deficits in Executive Functioning Scale (K-BDEFS)

    The Korean version of Barkley Deficits in Executive Functioning Scale measures executive functions of adults in everyday life. The score range is 89-356. Higher score indicates worse executive functioning.

    Measured: 1 week before the intervention, between 5th and 6th session of the intervention and 1-3 week after the intervention.

  2. The change in the Korean version of Vineland Adaptive Behavior Scale-II (K-Vineland-II)

    The Korean version of Vineland Adaptive Behavior Scale-II measures adaptive behavior. The scores are converted into a standard score with a mean of 100 and a standard deviation of 15. Higher score indicates better adaptive functioning.

    Measured: 1 week before the intervention and 1-3 week after the intervention.

  3. The change in the Community Integration Skills Assessment-2 (CISA-2)

    The Community Integration Skills Assessment-2 measures adaptive skills necessary for people with developmental disorders to integrate into the community. The scores are converted into a standard score with a mean of 100 and a standard deviation of 15. Higher score indicates better community integration skills.

    Measured: 1 week before the intervention and 1-3 week after the intervention.

  4. The change in the Cognitive Flexibility Inventory (CFI)

    The Cognitive Flexibility Inventory assesses cognitive flexibility. The score range is 19-113. Higher score indicates better cognitive flexibility.

    Measured: 1 week before the intervention and 1-3 week after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2020
  2. Study start11 Dec 2019
  3. Primary completion11 Mar 2020
  4. Study completion11 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
7 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04418492
Sponsor's protocol ID
B-1904/537-302
Status last verified
May 2020
First submitted
21 May 2020
Last updated
9 Jun 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Skills for Adaptive Functioning through Executive training (SAFE; tentative title) in people with Autism Spectrum Disorder and High-functioning Autism, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The change in the Korean version of Barkley Deficits in Executive Functioning Scale (K-BDEFS) (time frame: 1 week before the intervention, between 5th and 6th session of the intervention and 1-3 week after the intervention.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2020; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in